Lu et al. (2020) demonstrated that increased Th17 cells and decreased Treg cells aggravated myocardial fibrosis by activating the IL-17/ERK1/2-AP-1 pathway. This trend was also observed in immune remodeling in AF (He et al., 2018). The gene discussed is IL17A; the disease is atrial fibrillation.